| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 9,000 | $30 | $306K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 26,450 | $10 | $290.9K |
| J0897 | Injection, denosumab, 1 mg | 8,220 | $20 | $148K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 13,650 | $10 | $109.2K |
| J3262 | Injection, tocilizumab, 1 mg | 13,800 | $10 | $69K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 15,200 | $1 | $60.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 360 | $80 | $29.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 190 | $100 | $18.8K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 320 | $60 | $18.8K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 110 | $110 | $11.9K |